Jian-Xing Luo

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Hepatitis B Virus

Prognostic Factors

Placebo Controlled

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhang, Jian-Xing Luo, Yan-Ge Li, Hong-Fang Fu, Fang Yang, Xiao-Yu Hu
An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Yang Zhang, Yi-Tong Wang, Jian-Xing Luo, Xiao-Yu Hu, Fang Yang, Wu Lin, Xiao Liang, Bing-Jie Zhao, Song Zhang, Yuan-Yuan Chen
Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20-30 Times the ULN). Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Jian-Xing Luo, Yang Zhang, Xiao-Yu Hu, Chang Yu
The Effect of Modified Sini Decoction on Survival Rates of Patients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)